Wird geladen...
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
Neuromyelitis optica spectrum disorders (NMOSDs) is a new concept which includes classical neuromyelitis optica (NMO) and partial forms of NMO such as recurrent optic neuritis with positive aquaporin-4 antibodies (AQP4) or brainstem symptoms (intractable hiccups or vomiting). This disease is clearly...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Neurol Disord |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4811013/ https://ncbi.nlm.nih.gov/pubmed/27134673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616632653 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|